奥精医疗：人工骨修复材料在越南获批

Core Viewpoint - The company has received approval from the Vietnamese Ministry of Health for its OssaNova artificial bone repair material, marking a significant step in its overseas business expansion [1] Group 1: Product Development - OssaNova is developed using the company's proprietary in vitro biomimetic mineralization technology [1] - The product is designed for bone defect repair in oral and plastic surgery where there are no contraindications for bone grafting [1] - The material promotes bone regeneration while being gradually replaced by new bone tissue after implantation [1] Group 2: Market Expansion - The registration of the product in Vietnam is a crucial part of the company's strategy to expand its overseas business [1] - This approval is expected to boost the sales of the company's products in international markets [1]